14 Results for "

Nek2 kinase

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "Nek2 kinase" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-122639
CAS No.: 591239-68-8
Purity:  99.33%
Target:  

NEKs

Research Areas:  

Cancer

ZINC05007751 is a potent NIMA-related kinase NEK6 inhibitor with an IC50 of 3.4 μM. ZINC05007751 shows antiproliferative activity against a panel of human cancer cell lines, and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line. ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity was observed against NEK2, NEK7, and NEK9 .
loading...
    loading...
Cat. No.: HY-116423
CAS No.: 1311143-71-1
Purity:  98.99%
Target:  

NEKs

Research Areas:  

Cancer

JH295 is a potent, irreversible and selective NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 770 nM. JH295 inhibits cellular Nek2 via alkylation of Cys22. JH295 is inactive against the mitotic kinases, Cdk1, Aurora B or Plk1, and does not perturb bipolar spindle assembly or the spindle assembly checkpoint . JH295 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-101029
CAS No.: 2083622-09-5
Purity:  99.47%
Target:  

NEKs Apoptosis

Research Areas:  

Cancer

MBM-55 is a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 1 nM. MBM-55 shows a 20-fold or greater selectivity in most kinases with the exception of RSK1 (IC50=5.4 nM) and DYRK1a (IC50=6.5 nM). MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55 shows antitumor activities, and no obvious toxicity to mice .
loading...
    loading...
Cat. No.: HY-101030A
CAS No.: 2083621-91-2
Target:  

NEKs Apoptosis

Research Areas:  

Cancer

MBM-17S is a potent NIMA-related kinase 2 (Nek2) inhibitor, with an IC50 of 3 nM. MBM-17S effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-17S shows antitumor activities, and no obvious toxicity to mice .
loading...
    loading...
Cat. No.: HY-120330
CAS No.: 1507367-00-1
Target:  

NEKs Mitosis

Research Areas:  

Cancer

Nek2-IN-5 (compound 6) is a potent and irreversible Nek2 ((Never in mitosis gene a)-related kinase 2) inhibitior . Nek2-IN-5 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-150046
CAS No.: 2410376-96-2
Target:  

NEKs

Research Areas:  

Cancer

Nek2-IN-6 (Compound 28e) is a potent never in mitosis (NIMA) related kinase 2 (Nek2) inhibitor .
loading...
    loading...
Cat. No.: HY-101030
CAS No.: 2083621-90-1
Target:  

NEKs Apoptosis

Research Areas:  

Cancer

MBM-17 is a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 3 nM. It effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55 shows antitumor activities, and no obvious toxicity to mice .
loading...
    loading...
Cat. No.: HY-116423A
CAS No.: 2714087-26-8
Purity:  ≥99.0%
Target:  

NEKs

Research Areas:  

Cancer

JH295 hydrate is a potent, irreversible and selective NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 770 nM. JH295 hydrate inhibits cellular Nek2 via alkylation of Cys22. JH295 hydrate is inactive against the mitotic kinases, Cdk1, Aurora B or Plk1, and does not perturb bipolar spindle assembly or the spindle assembly checkpoint . JH295 (hydrate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-101029A
CAS No.: 2083624-07-9
Research Areas:  

Cancer

MBM-55S is a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 1 nM. MBM-55S shows a 20-fold or greater selectivity in most kinases with the exception of RSK1 (IC50=5.4 nM) and DYRK1a (IC50=6.5 nM). MBM-55S effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55S shows antitumor activities, and no obvious toxicity to mice .
loading...
    loading...
Cat. No.: HY-P702739
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: Nek2; Protein Phosphatase 1, Regulatory Subunit 111; NIMA Related kinase 2; Never In Mitosis A-Related kinase 2; Nek2A; NimA-Related Protein kinase 2; NLK1; NimA-Like Protein kinase 1; Serine/Threonine-Protein kinase Nek2; HsPK 21; PPP1R111; HSPK 21; RP67
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701822
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Nek2; Protein Phosphatase 1, Regulatory Subunit 111; NIMA Related kinase 2; Never In Mitosis A-Related kinase 2; Nek2A; NimA-Related Protein kinase 2; NLK1; NimA-Like Protein kinase 1; Serine/Threonine-Protein kinase Nek2; HsPK 21; PPP1R111; HSPK 21; RP67
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701823
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: Nek2; Protein Phosphatase 1, Regulatory Subunit 111; NIMA Related kinase 2; Never In Mitosis A-Related kinase 2; Nek2A; NimA-Related Protein kinase 2; NLK1; NimA-Like Protein kinase 1; Serine/Threonine-Protein kinase Nek2; HsPK 21; PPP1R111; HSPK 21; RP67
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-111090
CAS No.: 929095-23-8
Research Areas:  

Cancer

GSK461364 analogue 1 is a thiophene-based PLK1 inhibitor with a PLK1 IC50 of 2 nM and a PLK3 IC50 of 630 nM. GSK461364 analogue 1 also acts as an inhibitor of Nek2 kinase (IC50: 21 nM). GSK461364 analogue 1 has a solubility of ≥190 μM in pH 7.4 PBS and a human plasma protein binding rate of 91.5%. GSK461364 analogue 1 can be used in studies related to colon cancer, lung cancer, breast cancer and ovarian cancer .
loading...
    loading...
Cat. No.: HY-101029R
CAS No.: 2083622-09-5
Research Areas:  

Cancer

MBM-55 (Standard) is the analytical standard of MBM-55 (HY-101029). This product is intended for research and analytical applications. MBM-55 is a potent NIMA-related kinase 2 (Nek2) inhibitor with an IC50 of 1 nM. MBM-55 shows a 20-fold or greater selectivity in most kinases with the exception of RSK1 (IC50=5.4 nM) and DYRK1a (IC50=6.5 nM). MBM-55 effectively inhibits the proliferation of cancer cells by inducing cell cycle arrest and apoptosis. MBM-55 shows antitumor activities, and no obvious toxicity to mice .
loading...
    loading...
  • 1